GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (OTCPK:TRJNF) » Definitions » ROE % Adjusted to Book Value

TRJNF (Trajan Group Holdings) ROE % Adjusted to Book Value : -4.59% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Trajan Group Holdings ROE % Adjusted to Book Value?

Trajan Group Holdings's ROE % for the quarter that ended in Dec. 2024 was -6.61%. Trajan Group Holdings's PB Ratio for the quarter that ended in Dec. 2024 was 1.44. Trajan Group Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -4.59%.

Trajan Group Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Trajan Group Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trajan Group Holdings ROE % Adjusted to Book Value Chart

Trajan Group Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24
ROE % Adjusted to Book Value
- - - -

Trajan Group Holdings Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only - - - - -4.59

Competitive Comparison of Trajan Group Holdings's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trajan Group Holdings's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Trajan Group Holdings's ROE % Adjusted to Book Value falls into.


;
;

Trajan Group Holdings ROE % Adjusted to Book Value Calculation

Trajan Group Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-21.67% / N/A
=N/A

Trajan Group Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-6.61% / 1.44
=-4.59%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trajan Group Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Trajan Group Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Trajan Group Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (OTCPK:TRJNF) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
ASX:AHC ASX:SDI ASX:OSX ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM BAX COO WST XTER:SRT HOLX SOLV ALGN
Traded in Other Exchanges
TRJ:Australia
Address
7 Argent Place, Ringwood, VIC, AUS, 3134
Website
https://www.trajanscimed.com
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental sample. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and Consumables that includes parts, supplies, components and consumable products across the world. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).